This prospective study evaluated serum procalcitonin (PCT) and C-reactive protein (CRP) as markers for systemic inflammatory response syndrome (SIRS)/sepsis and mortality in patients with traumatic brain injury and subarachnoid haemorrhage. Sixty-two patients were followed for 7 days. Serum PCT and CRP were measured on days 0, 1, 4, 5, 6 and 7. Seventy-seven per cent of patients with traumatic brain injury and 83% with subarachnoid haemorrhage developed SIRS or sepsis (P=0.75). Baseline PCT and CRP were elevated in 35% and 55% of patients respectively (P=0.03). There was a statistically non-significant step-wise increase in serum PCT levels from no SIRS (0.4±0.6 ng/ml) to SIRS (3.05±9.3 ng/ml) to sepsis (5.5±12.5 ng/ml). A similar trend was noted in baseline PCT in patients with mild (0.06±0.9 ng/ml), moderate (0.8±0.7 ng/ml) and severe head injury (1.2±1.9 ng/ml). Such a gradation was not observed with serum CRP. There was a non-significant trend towards baseline PCT being a better marker of hospital mortality compared with baseline CRP (ROC-AUC 0.56 vs 0.31 respectively). This is the first prospective study to document the high incidence of SIRS in neurosurgical patients. In our study, serum PCT appeared to correlate with severity of traumatic brain injury and mortality. However, it could not reliably distinguish between SIRS and sepsis in this cohort. This is in part because baseline PCT elevation seemed to correlate with severity of injury. Only a small proportion of patients developed sepsis, thus necessitating a larger sample size to demonstrate the diagnostic usefulness of serum PCT as a marker of sepsis. Further clinical trials with larger sample sizes are required to confirm any potential role of PCT as a sepsis and outcome indicator in patients with head injuries or subarachnoid haemorrhage.
One of the accompaniments of traumatic brain injury and subarachnoid haemorrhage is an inflammatory response, very similar to the systemic inflammatory response syndrome described by the consensus conference 1 . The precise incidence of this phenomenon in these cohorts of patients has not been quantified. The local inflammatory response mediated by elevated levels of pro-inflammatory cytokines is thought to be an important player in the development of vasogenic oedema after traumatic brain injury.
Another important complication of both traumatic brain injury and subarachnoid haemorrhage is the development of nosocomial sepsis, particularly pneumonia and ventriculitis. The increased predisposition to pneumonia is multifactorial: the need for endotracheal intubation and ventilation, greater likelihood of aspiration and reduction in the adequacy of cough response. The increase in frequency of ventriculitis results from head trauma, penetrating foreign bodies and the frequent use of external ventricular drains for the monitoring of intracranial pressure.
However, sepsis in neuro-intensive care can be difficult to separate from the inflammatory response resulting from primary brain damage on clinical grounds or on the currently available laboratory parameters. This distinction may have diagnostic, therapeutic and prognostic implications. Reliable differentiation between the two syndromes may minimize the frequency of diagnostic investigations for sepsis workup, facilitate institution of appropriate antibiotic therapy and reduce the frequency of use of empiric antibiotic therapy [3] [4] [5] [6] . The ability to reliably distinguish between systemic inflammatory response syndrome (SIRS) and sepsis remains an unmet challenge. Currently available markers such as the total white cell count, serum CRP, IL-6 and neopterin are limited by their poor sensitivity and lack of specificity 7, 8 .
In the last decade, serum procalcitonin (PCT) has emerged as a new diagnostic marker of severe bacterial infection and septic shock in both adults and in children, irrespective of their immunological status and possibly superior to the conventional biological markers as an indicator of bacterial infection [9] [10] [11] [12] . Absolute values and sequential changes in PCT in response to therapy have also been reported to have prognostic significance in a variety of clinical states [13] [14] [15] . Persistent elevations of PCT are associated with increased length of stay, multiple organ dysfunction and mortality. Amongst the proposed markers of sepsis, PCT appears to be most promising in terms of its diagnostic value and prognostic ability. However, there is little published data on the usefulness of serum PCT in patients with traumatic brain injury and subarachnoid haemorrhage 16 .
We therefore undertook a prospective study to examine the following questions: a) What is the incidence of SIRS and sepsis in patients with traumatic brain injury and subarachnoid haemorrhage using the consensus criteria? b) Do serum PCT and CRP help to differentiate between SIRS and sepsis in traumatic brain injury and subarachnoid haemorrhage? c) To compare the relative sensitivities and specificities of PCT with CRP in identifying infection in these patients, and d) To examine if serum levels of PCT or CRP bear any relationship to mortality.
MATERIALS AND METHODS
The study protocol was approved by the Royal Brisbane Hospital Ethics Committee. As only leftover blood from routine sampling was to be analysed for CRP and PCT, the need for informed consent was waived.
Between April and December 2001 all patients with isolated head injury or acute aneurysmal sub-arachnoid haemorrhage in the last 48 hours were included in the study.
The following patients were excluded: 1. Patients already on antibiotics on admission to the unit. 2. Patients with pre-existing febrile illness.
Clinical care of patients
All patients in the ICU had continuous ECG and arterial pressure monitoring as part of standard clinical practice. When patients required sedation for intensive care procedures, facilitation of positive pressure ventilation or transport, propofol (1-3 mg/kg/h) in combination with alfentanil (10-20 µg/kg/h) or midazolam (0.1-0.2 mg/kg/h) in combination with fentanyl (1-2 µg/kg/h) were used. Endotracheal intubation was performed and positive pressure ventilation initiated when clinically indicated.
The clinical care of patients with head injury was based on the criteria developed by the Brain Trauma Foundation and the American Association of Neurological Surgeons 17, 18 .
Four-vessel cerebral angiography was performed in patients with subarachnoid haemorrhage within 48 hours of admission to the hospital to identify the location of the aneurysm. In all patients, intravenous nimodipine infusion was commenced at an initial infusion rate of 5 µg/kg/h which was progressively increased over a five-hour period to a maximum dose of 30 µg/kg/h. All patients were then maintained on this dose for a week unless the presence of sideeffects such as hypotension dictated the reduction in the dose or total cessation of nimodipine.
Clinical data collection
In those patients who had ICP and CPP monitoring, the daily maximum, minimum and mean values of these were recorded. The APACHE II and Glasgow Coma Scores were also collected.
Measurement of Serum Procalcitonin and CRP
Serum PCT and CRP were measured on days 0 (day of admission), 1, 4, 5, 6 and 7. The serum left over after analysis of biochemistry analytes was used in the analysis of both CRP and PCT. No additional blood was withdrawn.
PCT was measured in the serum using an immunolumimetric assay 19,20 . The detection limit for the assay is 0.1 ng/ml and the coefficient of variation, between 1-1000 ng/ml, is 5-10%. The assay is also free of interference from the antibiotics, sedatives and vasoactive agents that are commonly used in the intensive care unit. Serum PCT levels were also assayed in four samples from three of the investigators (healthy volunteers) and the results used as controls and for quality assurance.
Serum CRP was measured in the hospital laboratory by rate nephelometry using the IMMAGE Immunochemistry system (Beckman, Gladesville, N.S.W.).
Definitions of study groups
Identification of SIRS and sepsis was based on the guidelines developed at the Consensus Conference of the American College of Chest Physicians and the Society of Critical Care Medicine 1 .
Infection was defined as a microbial phenomenon characterized by an inflammatory response to the presence of microorganisms or the invasion of normally sterile host tissue by those organisms.
A patient was considered to have an infection if a) there was documented SIRS b) a diagnostic work-up for an infection was initiated c) there was a positive culture of potentially pathogenic microorganisms d) there was a statement by the medical team of a high likelihood of infection and e) antibiotics were commenced.
All of the above criteria had to be met before a patient was considered to have an infection. Empiric antibiotic therapy for compound fractures was not considered to be equivalent to commencing antibiotics for an infection.
The presence or absence of infection by type was documented according to standard definitions of the Centers for Disease Control and Prevention (CDC) 21 .
Blinding: The treating clinician was blinded to the results of the serum PCT and CRP assays and the research personnel performing the PCT assay was blinded to the patient's clinical and other investigative data.
Microbiological follow up
The following specimens were sent for microbiological testing from all patients: 1) Daily cerebrospinal fluid specimens if there was an external ventricular drain. 2) Twice weekly endotracheal aspirates, catheter specimen of urine and a rectal swab as part of surveillance cultures. 3) Septic screens (blood, urine, endotracheal aspirates and line tips if appropriate) during episodes of fever and leucocytosis.
Outcome indices
The primary outcome indices examined in this study were development of sepsis and hospital mortality.
Data Analysis 22
Fisher's exact tests were used to assess the associations between incidence of SIRS or sepsis and diagnostic group or outcome. Regression models considered mean CRP levels over time, and whether or not these differed depending on diagnostic group or presence of SIRS or sepsis. Whether or not these relationships were stronger for some outcome groups than others was also explored by introducing an interaction term to the model. Adjustment was made for the potential confounding effects of patient age, sex, APACHE score and initial Glasgow Coma Score. A generalized estimating equations approach, defining an independent working correlation matrix, permitted (i) the specification of the repeated measures design, and (ii) the retention of partially complete observations (as not all measurements were available on all days of observation). Prior to analysis, CRP levels were normalized by a logarithmic transformation. Results are expressed as (geometric) means and 95% confidence intervals.
PCT levels were not able to be transformed. Hence medians rather than means, and ranges (minima, maxima) rather than standard deviations were used to describe the data. This restriction also meant that the regression models applied to CRP could not validly be applied to PCT levels, and analyses were restricted to non-parametric tests. Thus, no adjustment was possible for age, sex, APACHE score or initial Glasgow Coma Score, nor were interaction terms able to be considered on the original PCT data, other than through stratified analyses. PCT levels were averaged across the six days of observation and the average PCT was compared across sepsis groups using Kruskal-Wallis tests. Receiver operating characteristic (ROC) curves were generated for CRP and PCT levels to determine the overall ability of these markers to predict outcome. Statistical significance was reported at the conventional P<0.05 (two-tailed) level. All statistical pairwise comparisons were based on model-based contrasts in each case for CRP levels and based on pairwise Mann-Whitney tests for PCT levels.
RESULTS
Sixty-three patients were enrolled, however, one patient was eliminated from the analysis due to lost data. The demographic data of the 62 patients are summarized in Table 1 . (Table 2) In the whole series, incidence of SIRS or sepsis was 77% in traumatic brain injury patients and 83% in subarachnoid haemorrhage patients, P=0.751, Fisher's exact test. The incidence of SIRS was 56% overall, however was significantly higher for the subarachnoid haemorrhage than traumatic brain injury group (46% TBI, 74% SAH, P=0.039, Fisher's exact test). The incidence of sepsis was 31% in traumatic brain injury versus 9% in subarachnoid haemorrhage, the difference not quite attaining statistical significance (Fisher's exact test, P=0.061).
Incidence of SIRS and sepsis
There were 14 episodes of infection in these patients (10 pneumonia, 1 blood stream, 2 ventriculitis and 1 urinary tract infection).
Serum procalcitonin and CRP concentrations
The mean serum PCT in the control population was 0.3±0.05 ng/ml. In the overall patient population, baseline PCT and CRP were elevated in 35% and 55% respectively (P=0.03). Overall, there appeared to be no specific relationship between serum PCT and CRP concentrations on the one hand and the development of sepsis. However, there was a stepwise increase in serum PCT concentrations in patients with levels in sepsis+SIRS>>SIRS>>no SIRS. In contrast to PCT, no trends in serum concentrations of CRP were observed between no SIRS, SIRS and sepsis in the overall patient population or in the individual subgroups ( Table 3 and Figure 1) . Although there was a trend towards a higher serum PCT level in sepsis than in SIRS, this did not reach statistical significance.
Amongst those patients with sepsis, there was a trend towards a higher concentration of serum procalcitonin in those patients with pneumonia as compared to other infections (15±23 ng/ml vs 0.4± 0.04 ng/ml, P=0.09). Based on previously published data that showed no PCT elevation in ventriculitis and urinary infections, we compared PCT and CRP levels in patients with chest infections (15±23 ng/ml) with the non-septic group (4±14 ng/ml) and were not able to demonstrate statistically significant differences (P=0.2).
Relationship between PCT and sickness severity indices
Neither the mean nor the peak levels of PCT bore any relationship to APACHE scores or ICP in patients with head trauma.
Relationship between serum PCT and CRP vs mortality
Baseline, mean, and peak CRP and PCT were considered in these analyses (Table 4 ). Neither CRP nor PCT was a particularly sensitive or specific marker of mortality. The small sample size meant that there were wide overlapping, confidence intervals around all these estimates, and hence no statistically signifi- cant differences in the discriminatory power of CRP and PCT. To achieve a low false positive rate (specificity of 80% or greater), neither marker achieved a sensitivity of better than 67%. At baseline there was once again a non-significant trend towards PCT being better than CRP as an indicator of mortality, thus raising the possibility that serum PCT concentrations might reflect the severity of brain injury.
To look at this issue, we examined the relationship between the initial GCS (a validated marker of severity of head trauma) and baseline PCT levels (Figure 2 ). There was a step-wise increase in baseline serum PCT levels with increasing severity of head injury with a statistically significant difference in serum PCT levels between patients with minor head injury as compared to those with moderate and severe head injury.
DISCUSSION
The results clearly demonstrate the high incidence of SIRS in patients with traumatic brain injury and subarachnoid haemorrhage during the first week of their illness. To our knowledge, this is the first prospective evaluation of the incidence of SIRS in this condition. A retrospective study of patients with aneurysmal subarachnoid haemorrhage documented a similar incidence of SIRS 23 .The apparent higher incidence of SIRS in patients with subarachnoid haemorrhage may be due to combination of central pyrexia and the invariable use of nimodipine which frequently results in the need for pressor therapy.
This high incidence of SIRS illustrates the dilemma facing clinicians, when it comes to diagnosing sepsis in these cohorts. It is for this reason that we examined the usefulness of PCT as a marker of sepsis in these patients. In some patients, particularly those with TBI, PCT was found to be elevated on Day 1 even before sepsis could have occurred. This clouds the value of PCT as a specific marker of sepsis in these patients.
As noted, although there was a trend towards serum PCT being a better marker of sepsis than CRP. The results did not reach statistical significance. There are a number of possible explanations for this finding. Firstly, the gold standard for diagnosis of infection does not exist. Although we used a widely accepted clinical definition of infection, it is likely that that many infected patients may have been categorized as having SIRS (without sepsis) if the culture result was negative. Secondly, certain infections such as lower urinary tract infections 24 and ventriculitis 16 do not result in significant elevations in PCT. Another possibility is that we measured PCT only till the end of the 1st week following admission. There could have been a lag between the development of sepsis and elevations in PCT. It is also possible that elevations in PCT might have been missed in those patients who developed sepsis towards the end of the first week. Fourthly, as noted, it is important to recognize that brain damage (from traumatic brain injury or subarachnoid haemorrhage) per se results in an elevated PCT, thus introducing some background noise into the analysis. This, combined with the findings in previously published data where various cutoff levels of serum PCT have been observed in a variety of infections may further confound the interpretation of serum PCT. Still another explanation to consider is the small proportion of patients who developed sepsis, thus a larger sample size might have resulted in statistical significance. From the standard deviations of PCT in the SIRS and the sepsis groups, a sample size of 62 only reached 20% power to detect a difference in PCT of 2 ng/ml. Nevertheless, the study has identified trends that could form the basis of definitive trial in the future.
The presence of a step-wise increase in baseline PCT concentrations with increasing severity of head injury supports the hypothesis that serum PCT may in fact reflect the severity of the underlying head injury.
What is the biological basis for such a hypothesis? Although the precise biological source of procalcitonin remains to be clarified, CALC-I gene (the gene which encodes PCT) expression has been demonstrated in the human brain tissue 25 . It is therefore likely that the injured brain might express higher levels of the gene leading to increased synthesis of PCT in the central nervous system. Evidence to support this hypothesis comes from another study which demonstrated elevated CSF PCT levels in paediatric patients suffering from head injury 26 . Also, an increase in the expression of the CALC-I gene in the brain in response to sepsis has been demonstrated in animal models, further contributing to the elevations in serum PCT 27 . These may also explain the observed trend between PCT concentrations and outcome.
Other possible explanations for the increase in serum PCT include increased IL-6 production after head trauma 2 . Increases in IL -6 are thought to stimulate PCT synthesis through as yet undefined mechanisms.
In conclusion, we have demonstrated the high incidence of SIRS and sepsis in this population group. We have also shown that serum PCT concentrations are elevated soon after head injury prior to the onset of sepsis. There appeared to be non-significant trends in serum PCT as a marker of sepsis as well as a predictor of mortality. The inability of PCT to distinguish between SIRS and sepsis in this cohort is in because baseline PCT elevation seemed to correlate with severity of injury. Besides, only a small proportion of patients developed sepsis, thus necessitating a larger sample size to demonstrate the diagnostic usefulness of serum PCT as a marker of sepsis. Further clinical trials with larger sample sizes are required to confirm any potential role of PCT as a sepsis and outcome indicator in patients with head injuries or subarachnoid haemorrhage.
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